Annual ROE
-82.35%
-35.16%-74.51%
31 December 2023
Summary:
Amneal Pharmaceuticals annual return on equity is currently -82.35%, with the most recent change of -35.16% (-74.51%) on 31 December 2023. During the last 3 years, it has fallen by -108.68% (-412.76%). AMRX annual ROE is now -412.76% below its all-time high of 26.33%, reached on 31 December 2020.AMRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-587.29%
-353.59%-151.30%
30 September 2024
Summary:
Amneal Pharmaceuticals quarterly return on equity is currently -587.29%, with the most recent change of -353.59% (-151.30%) on 30 September 2024. Over the past year, it has dropped by -592.80% (-10758.62%). AMRX quarterly ROE is now -2440.73% below its all-time high of 25.09%, reached on 31 December 2020.AMRX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMRX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -74.5% | -10000.0% |
| 3 y3 years | -412.8% | -10000.0% |
| 5 y5 years | -26.3% | -1203.3% |
AMRX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -412.8% | at low | <-9999.0% | at low |
| 5 y | 5 years | -412.8% | at low | -2440.7% | at low |
| alltime | all time | -412.8% | at low | -2440.7% | at low |
Amneal Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -587.29%(+151.3%) |
| June 2024 | - | -233.70%(+49.6%) |
| Mar 2024 | - | -156.24%(+175.5%) |
| Dec 2023 | -82.35%(+74.5%) | -56.72%(-1129.4%) |
| Sept 2023 | - | 5.51%(-605.5%) |
| June 2023 | - | -1.09%(-98.1%) |
| Mar 2023 | - | -58.04%(+22.0%) |
| Dec 2022 | -47.19%(-1683.6%) | -47.58%(+12.8%) |
| Sept 2022 | - | -42.18%(+9.8%) |
| June 2022 | - | -38.41%(-8450.0%) |
| Mar 2022 | - | 0.46%(-84.0%) |
| Dec 2021 | 2.98% | 2.87%(-24.7%) |
| Sept 2021 | - | 3.81%(+50.6%) |
| June 2021 | - | 2.53%(-153.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | -4.72%(-118.8%) |
| Dec 2020 | 26.33%(-145.2%) | 25.09%(+51.1%) |
| Sept 2020 | - | 16.61%(-138.8%) |
| June 2020 | - | -42.81%(+16.0%) |
| Mar 2020 | - | -36.91%(-35.0%) |
| Dec 2019 | -58.23%(-10.7%) | -56.76%(+26.0%) |
| Sept 2019 | - | -45.06%(+482.2%) |
| June 2019 | - | -7.74%(-81.7%) |
| Mar 2019 | - | -42.38%(+48.3%) |
| Dec 2018 | -65.18%(+50.0%) | -28.58%(+41.8%) |
| Sept 2018 | - | -20.16%(-86.2%) |
| June 2018 | - | -146.30%(+218.3%) |
| Mar 2018 | - | -45.97%(+41.0%) |
| Dec 2017 | -43.46% | -32.61% |
FAQ
- What is Amneal Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual ROE year-on-year change?
- What is Amneal Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly ROE year-on-year change?
What is Amneal Pharmaceuticals annual return on equity?
The current annual ROE of AMRX is -82.35%
What is the all time high annual ROE for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual return on equity is 26.33%
What is Amneal Pharmaceuticals annual ROE year-on-year change?
Over the past year, AMRX annual return on equity has changed by -35.16% (-74.51%)
What is Amneal Pharmaceuticals quarterly return on equity?
The current quarterly ROE of AMRX is -587.29%
What is the all time high quarterly ROE for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly return on equity is 25.09%
What is Amneal Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, AMRX quarterly return on equity has changed by -592.80% (-10758.62%)